logo
Plus   Neg
Share
Email

PDL BioPharma Inc. Q1 Income Climbs

PDL BioPharma Inc. (PDLI) released earnings for its first quarter that climbed from last year.

The company's bottom line totaled $6.68 million, or $0.05 per share. This compares with $1.60 million, or $0.01 per share, in last year's first quarter.

Analysts had expected the company to earn $0.08 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 1.0% to $38.91 million from $38.52 million last year.

PDL BioPharma Inc. earnings at a glance:

-Earnings (Q1): $6.68 Mln. vs. $1.60 Mln. last year.
-EPS (Q1): $0.05 vs. $0.01 last year.
-Analysts Estimate: $0.08
-Revenue (Q1): $38.91 Mln vs. $38.52 Mln last year.

For comments and feedback contact: editorial@rttnews.com

Follow RTT
>